MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/17460441.2018.1508206

Медицинская библиотека · Expert opinion on drug discovery · 2018

The use of biomarkers as a tool for novel psoriatic disease drug discovery.

Aggarwal Dinesh, Arumalla Nikita, Jethwa Hannah, Abraham Sonya

СтатьяОбзорПеревод в очереди

Аннотация

Psoriatic disease is a relatively new term which encompasses psoriatic arthritis, psoriasis, and associated comorbidities. In this heterogeneous condition, the study of biomarkers is necessary to direct best therapy. Resulting in significant disability and socioeconomic burden, recent recommendations stress the need for tight control in psoriatic disease. Areas covered: The authors outline recent advances in the understanding of psoriatic disease pathogenesis which has highlighted multiple biomarkers that have been pursued as drug targets with varying degrees of success. Current drugs targeting biomarkers and therapies in development are evaluated. The methods of biomarker discovery through genomics, transcriptomics, proteomics, metabolomics, and study of the microbiome are also discussed. Expert opinion: Targeting biomarkers for therapeutic benefit appears to a promising field with multiple success stories, notably those associated with signaling through T-helper-17 cells. The use of genomics, transcriptomics, proteomics, and more recently metabolomics will help individualize targeted biomarker therapies, assist in monitoring therapeutic success, and ultimately yield novel therapeutic targets. Advances in the development of novel biologic molecules targeting more than one cytokine may offer additional gains in therapeutic response.

Для цитирования: Aggarwal Dinesh, Arumalla Nikita, Jethwa Hannah, Abraham Sonya. The use of biomarkers as a tool for novel psoriatic disease drug discovery.. Expert opinion on drug discovery. 2018. DOI: 10.1080/17460441.2018.1508206.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.